K2M claims that Ravine provides a dual flat blade platform for a true muscle splitting transpsoas approach, which offers rigid fixation to the spine and an option for both a third and fourth blade.
It represents an innovative design departure from the tubular retractors, while providing tremendous adaptability to both patient anatomy and surgeon technique.
Aleutian Lateral is comprised of anatomically designed interbody implants made of PEEK material that are used in conjunction with the Ravine Retractor.
The implants feature radiolucent properties, which have the potential to increase visualization of bone graft while aiding in accurate fusion assessment.
The bulleted nose allows for ease of insertion and the circumferential rings provide 360 degrees of grip to the endplates.
K2M president and CEO Eric Major said CE Mark clearance for Ravine and Aleutian Lateral expands the K2M minimally invasive product offering and fuels their rapid international growth in spine market.
